National Children's Innovation GeNose Will Be Released 3,000 Units In February

JAKARTA - A rapid screening tool for COVID-19 through exhalation, a product made by the nation's children, GeNose, will be released in February. GeNose has obtained a distribution permit from the Ministry of Health.

"For the February target, we are now calculating, we are targeting 3,000 February releases Insyaallah," said Head of Consortium GeNose C19 Production Eko Fajar Prasetyo, in a webinar, Friday, January 15.

GeNose is a nationwide rapid screening tool whose test is different from the antigen or swab test. Exhale-based GeNose tests.

Later, if the patient's exhalation sample uses a positive GeNose, it must still be validated using the standard PCR swab test.

Meanwhile, Minister of Research and Technology / National Research and Innovation Agency Bambang Brodjonegoro revealed that the innovative COVID-19 test kits from the nation's children were flooded with orders.

According to Bambang, orders that have been received have even exceeded production capacity. For that, he asked the industries involved in GeNose production to increase production capacity.

"From the industrial side, please ensure that besides we can fulfill orders that have come, which I know is far from the current production capacity. However, we hope that the production capacity can catch up soon," said Bambang.